中文 | English
Return
Total: 34 , 1/4
Show Home Prev Next End page: GO
MeSH:(Pyrimidines/adverse effects*)

2.Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review.

Bingcheng LIU ; Ying WANG ; Yingchang MI ; Jianxiang WANG

Chinese Journal of Hematology 2014;35(7):581-586

4.Anterior Ischemic Optic Neuropathy Associated with Udenafil.

In Gun KIM ; Dae Yune KIM

Korean Journal of Ophthalmology 2012;26(3):235-238

5.Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong.

Vivian W Y LEE ; T S CHAU ; Vice P H LEUNG ; Kenneth K C LEE ; Brian TOMLINSON

Chinese Medical Journal 2009;122(23):2814-2819

6.A Case of Pseudomembranous Colitis after Voriconazole Therapy.

Jae Cheol KWON ; Min Kyu KANG ; Si Hyun KIM ; Su Mi CHOI ; Hee Je KIM ; Woo Sung MIN ; Dong Gun LEE

Yonsei Medical Journal 2011;52(5):863-865

8.Reversible Dysphasia and Statins.

Gordon Robert Wyndham DAVIES

Journal of Korean Medical Science 2012;27(4):458-459

9.Efficacy and safety analysis of interferon combined with imatinib in treating chronic myeloid leukemia.

Yang LIU ; Er-Ning BAO ; Wen-Wen ZHONG ; Xue-Chun LU ; Hong-Li ZHU

Journal of Experimental Hematology 2014;22(2):304-309

10.The Clinical Observation with Ruxolitinib as Graft-Versus-Host Disease Prophylaxis for Children with Thalassemia after Unrelated or Haploidentical Allo-Hematopoietic Stem Cell Transplantation.

Ya-Mei CHEN ; Xiu-Li HONG ; Jin-Zong LIN ; Jie SHI ; Quan-Yi LU

Journal of Experimental Hematology 2022;30(5):1586-1589

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 34 , 1/4 Show Home Prev Next End page: GO